(Q36072570)

12 August 2017

1 reference

title

Review article: hepatitis C virus infection and type-2 diabetes mellitus in renal diseases and transplantation (English)

1 reference

12 August 2017

1 reference

Fabrizi F

1

1 reference

12 August 2017

Lampertico P

2

1 reference

12 August 2017

Lunghi G

3

1 reference

12 August 2017

Mangano S

4

1 reference

12 August 2017

Aucella F

5

1 reference

12 August 2017

Martin P

6

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

Alimentary Pharmacology & Therapeutics

12 August 2017

1 reference

12 August 2017

21

1 reference

12 August 2017

6

1 reference

12 August 2017

623-632

1 reference

National surveillance of dialysis-associated diseases in the United States, 2001.

12 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Hepatitis C infection and the patient with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Cryoglobulinaemia and hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Hepatitis C virus in patients with cryoglobulinemia type II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Membranoproliferative glomerulonephritis associated with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Idiopathic pulmonary fibrosis and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Multicenter study on hepatitis C virus infection in patients with dilated cardiomyopathy. North Italy Transplant Program (NITP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Prevalence of hepatitis C virus infection among patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Hepatitis C virus infection and heart diseases: a multicenter study in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Lichen planus and hepatitis C virus--related chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Rubella infection and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Association of diabetes mellitus and chronic hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

HCV and diabetes mellitus: evidence for a negative association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Post-liver transplantation diabetes mellitus: an association with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Diabetes mellitus after liver transplant new etiologic clues and cornerstones for understanding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Association between hepatitis C virus infection and development of posttransplantation diabetes mellitus in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Hepatitis C and the incidence of diabetes mellitus after renal transplant: influence of new immunosuppression protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Is hepatitis C a risk factor to posttransplant diabetes mellitus after renal transplantation in patients using tacrolimus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Posttransplant diabetes mellitus in renal transplant patients with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Diabetes mellitus after kidney transplantation in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome after renal transplantation in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02389.X

10.1111/J.1365-2036.2005.02389.X

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference